Search Results - "Sadaka, B."

Prospective Iterative Trial of Proteasome Inhibitor‐Based Desensitization by Woodle, E. S., Shields, A. R., Ejaz, N. S., Sadaka, B., Girnita, A., Walsh, R. C., Alloway, R. R., Brailey, P., Cardi, M. A., Abu Jawdeh, B. G., Roy‐Chaudhury, P., Govil, A., Mogilishetty, G.

“…A prospective iterative trial of proteasome inhibitor (PI)‐based therapy for reducing HLA antibody (Ab) levels was conducted in five phases differing in…”
Get full text

A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients by Alloway, R. R., Sadaka, B., Trofe‐Clark, J., Wiland, A., Bloom, R. D.

“…Pharmacokinetic analyses comparing generic tacrolimus preparations versus the reference drug in kidney transplant patients are lacking. A prospective,…”
Get full text

Randomized Controlled Pilot Study of B Cell–Targeted Induction Therapy in HLA Sensitized Kidney Transplant Recipients by Ejaz, N. S., Shields, A. R., Alloway, R. R., Sadaka, B., Girnita, A. L., Mogilishetty, G., Cardi, M., Woodle, E. S.

“…Optimal induction regimens for patients at high risk for antibody and/or cell–mediated rejection have not been established. This pilot, prospective, randomized…”
Get full text

30-P Differential antigen- and epitope-based reduction of HLA-specific antibody in renal transplant candidates under proteasome inhibitor-based desensitization by Girnita, A.L, Brailey, P, Sadaka, B, Rike-Shields, A, Cardi, M, Mogilishetty, G, Alloway, R.R, Woodle, E.S

Get full text

45-OR: Renal transplant patients with late antibody mediated rejection exhibit more IgG3 and/or multiple IgG subtype combinations when compared to early antibody mediated rejection by Girnita, A.L, Brailey, P, Portwood, E, Alloway, R.R, Rike-Shields, A, Sadaka, B, Woodle, E.S

Get full text

Early and Late Acute Antibody-Mediated Rejection Differ Immunologically and in Response to Proteasome Inhibition by CARLIN WALSH, R, BRAILEY, Paul, MOGILISHETTY, Gautham, ROY-CHAUDHURY, Prabir, WOODLE, E. Steve, GIRNITA, Alin, ALLOWAY, Rita R, RIKE SHIELDS, Adele, WALL, Garth E, SADAKA, Basma H, CARDI, Michael, TEVAR, Amit, GOVIL, Amit

“…The efficacy of plasma cell targeted therapies for antibody-mediated rejection (AMR) has not been defined in detail. The purpose of this study was to compare…”
Get full text

A Multicenter Experience With Generic Tacrolimus Conversion by MCDEVITT-POTTER, Lisa M, SADAKA, Basma, TICHY, Eric M, ROGERS, Christin C, GABARDI, Steven

“…The first generic tacrolimus product gained Food and Drug Administration approval in August 2009. This prospective, observational trial sought to determine the…”
Get full text

Prospective Evaluation of the Toxicity Profile of Proteasome Inhibitor―Based Therapy in Renal Transplant Candidates and Recipients by SCHMIDT, Nicole, ALLOWAY, Rita R, WALSH, R. Carlin, SADAKA, Basma, SHIELDS, Adele R, GIRNITA, Alin L, HANSEMAN, Dennis J, WOODLE, E. Steve

“…A prospective intermediate-term evaluation of toxicities associated with bortezomib therapy for antibody-mediated rejection (AMR) and desensitization was…”
Get full text